Benefits of Total Intravenous Anesthesia Compared With Inhaled Anesthesia in Cardiovascular Surgery

NCT03233815 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-08-06

No results posted yet for this study

Summary

This study compares the difference in proinflammatory markers Interleukin 6 (IL-6), Tumor necrosis factor alpha (TNFα) and cortisol in patients undergoing cardiovascular surgery to asses if there is a benefit of using intravenous total anesthesia (TIVA) over inhaled anesthesia for this procedures.

Conditions

  • Cardiovascular Surgical Procedure

Interventions

DRUG

Propofol

Propofol anesthesia Dose: 4-6mg/kg/h

DRUG

Sevoflurane

Inhaled anesthesia with sevoflurane. Dose: 1-2.5 Minimum Alveolar Concentration(MAC)

Sponsors & Collaborators

  • Coordinación de Investigación en Salud, Mexico

    lead OTHER_GOV

Principal Investigators

  • Ana Gallardo, PhD · Instituto Mexicano del Seguroa Social

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-13
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03233815 on ClinicalTrials.gov